SCHEMBL5656218

SCHEMBL5656218

COC(=O)c1cc(OC)c(OC)c2oc(C(=O)N3CCc4ccccc4C3)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
MAPT P10636 6/20 0.52
HTT P42858 3/20 0.52
LMNA P02545 2/20 0.52
TSHR P16473 2/20 0.52
HSD17B10 Q99714 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
TP53 P04637 1/20 0.52
ALOX15 P16050 1/20 0.52
MAPK1 P28482 1/20 0.52
HPGD P15428 4/20 0.52
KDM4E B2RXH2 5/20 0.50
ABCB1 P08183 3/20 0.49
PDE4B Q07343 3/20 0.48
PDE4D Q08499 2/20 0.48
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
MDM2 Q00987 1/20 0.46
NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659068 0.81 FABP6 (0.49) ALDH1A1MAPTTSHRKMT2AMEN1
SCHEMBL7689181 0.76 ALDH1A1 (0.49) ALDH1A1MAPTHTTLMNATSHR
SCHEMBL5659664 0.75 KMT2A (0.54) ALDH1A1MAPTHTTLMNAHSD17B10
SCHEMBL5669321 0.74 KDM4E (0.49) ALDH1A1MAPTHTTLMNAHSD17B10
SCHEMBL5661034 0.72 ACHE (0.55) ALDH1A1MAPTHTTHSD17B10TP53
SCHEMBL5659646 0.72 SMN1; SMN2 (0.47) ALDH1A1MAPTHTTLMNAHSD17B10
SCHEMBL5658605 0.71 KDM4E (0.44) ALDH1A1MAPTTSHRHSD17B10KMT2A
SCHEMBL5655755 0.71 KDM4E (0.46) ALDH1A1MAPTHTTLMNAHSD17B10
SCHEMBL5657180 0.71 KDM4E (0.46) ALDH1A1MAPTHTTLMNAHSD17B10
SCHEMBL5657720 0.71 KDM4E (0.46) ALDH1A1HTTTSHRHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR ALDH1A1 1365/4885MAPT 3343/4885HTT 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.